[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335597-105":59,"doc-detail-335597-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multifaceted-impact-of-hiv-inhibitor-dapivirine-on-triple-negative-breast-cancer-cells-reveals-potential-entities-as-targets-for-novel-therapy","Multifaceted impact of HIV inhibitor dapivirine on triple negative breast cancer cells reveals potential entities as targets for novel therapy","","Breast cancer subtype triple negative breast cancer (TNBC) lacks ER/PR/HER2 targets and has limited therapeutic options, with high relapse rates despite chemotherapy. This study investigates dapivirine, a HIV non-nucleoside reverse transcriptase inhibitor repurposable for cancer treatment. Dapivirine strongly inhibits MDA-MB-231 cells, induces ROS accumulation, apoptosis, caspase activation, and deregulates PCNA and signaling circuits spanning ECM, angiogenesis, adhesion, and immunomodulation, with potential stem-like cell effects via BTF3 and proteasome pathway modulation. Taken together, dapivirine shows promise for TNBC monotherapy or combination therapy and possibly dual HIV/TNBC treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multifaceted-impact-of-hiv-inhibitor-dapivirine-on-triple-negative-breast-cancer-cells-reveals-potential-entities-as-targets-for-novel-therapy/335597/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multifaceted-impact-of-hiv-inhibitor-dapivirine-on-triple-negative-breast-cancer-cells-reveals-potential-entities-as-targets-for-novel-therapy/335597.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why was dapivirine selected for study in triple negative breast cancer cells?","Question",{"text":112,"@type":113},"Dapivirine is an HIV NNRTI that can be detected in breast milk of lactating women treated for HIV, suggesting it could potentially target cancer cells. The study also focuses on drug repurposing to accelerate availability of effective therapies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does dapivirine affect TNBC cells compared with other NNRTIs?",{"text":117,"@type":113},"Dapivirine shows a potent impact on MDA-MB-231 TNBC cells, while NNRTIs such as nevirapine show only marginal effects. It also exhibits inhibition at higher concentrations on other breast cell lines.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular processes and pathways are implicated by dapivirine treatment?",{"text":121,"@type":113},"Molecular studies indicate increased reactive oxygen species, apoptotic cells, and caspase activation. Protein profiling and STRING analysis reveal deregulation of PCNA and effects on signaling circuits involving ECM, angiogenesis, cell adhesion, and immunomodulation, including potential stem-like cell influence via BTF3 and proteasome-related components.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335597,1791028543,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nMultifaceted impact of HIV inhibitor dapivirine on triple negative breast cancer cells reveals potential entities as targets for novel therapy  \nKetki Patil1,2, Elizabeth Johnston1,2, Joseph Novack1, Garrett Wallace1, Michelle Lin1 &  \nS. Balakrishna Pai1􀀍  \nBreast cancer is the most common cancer in women worldwide. Many breast cancers originate from the cells lining the milk duct and some become invasive. Breast cancer lacking estrogen, progesterone receptors (ER-, PR-) and epidermal growth factor receptor 2 (HER2-) amplification, termed “Triple negative”(TNBC) is reported to frequently affect Black women and younger women. TNBC is an invasive ductal carcinoma with limited treatment options. To this end, we opted to investigate drugs that could be repurposed because they offer advantages in bringing effective treatments faster to  \nthe clinic. We chose to study the effect of the drug, dapivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI) of HIV because it could be detected in the breast milk of lactating women when treated for HIV and the drug could potentially target the cancer. Here we show the potent impact of dapivirine on MDA-MB-231 TNBC cells, while NNRTI like nevirapine showed marginal effects. When dapivirine was tested on other breast cell lines, MCF-7 and MCF 10A, the inhibition was at higher concentrations. Molecular studies with dapivirine inTNBC cells, revealed an increase in reactive oxygen species (ROS), apoptotic cells, and activation of caspases. Importantly, protein profiling and STRING analysis revealed deregulation of the key molecule, PCNA and impact on pivotal cell signaling circuits including extracellular matrix (ECM), angiogenesis, cell adhesion, and immunomodulation. Of note, is its potential effect on stem-like cells due to downregulation of the basic transcription factor 3 (BTF3) and proteasome activator complex subunit 3; the latter affecting their dependence on the proteasome pathway. Taken together, dapivirine exhibits the potential to be considered as a repurposed drug for TNBC as monotherapy/combination therapy. Notably, it could also potentially be a treatment for individuals with dual ailments, such as HIV andTNBC, if the clinical outcomes with dapivirine forTNBC become favorable.  \nKeywords Triple negative breast cancer, Dapivirine, MDA-MB-231, Apoptosis, Proteomics, Multicaspase  \nThe most common malignancy occurring in women worldwide is cancer of the breast1,2. In many cases, breast cancers originate from the cells lining the milk duct, and are classified as ductal carcinomas3. When these cells become invasive, they are then categorized as invasive ductal carcinomas. Among the breast cancers, TNBC forms 10–15% of the cancers identified and is known to be heterogeneous; importantly, it is also more aggressive than other breast cancers4. Breast cancer with TNBC phenotype presents as an invasive ductal carcinoma and also exhibits biological variations5. Treatment options for TNBC are limited because they do not respond to hormonal therapies unlike other types of breast cancers; thus, TNBC is typically treated with chemotherapy. Although TNBC is considered chemosensitive, the cancer relapse rate is high due to its aggressive nature when compared to other breast cancers and assays for precision medicine have been reported6,7. While it can occur in anyone, the frequency of occurrence in Black women as well as younger women is higher. Considering that efficacious treatment options are limited for TNBC, novel therapeutic options are warranted8,9.  \n1Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 313 Ferst Drive, Atlanta, GA 30332, USA. 2These authors contributed equally: Ketki Patil and Elizabeth Johnston.  \n􀀍 email: [balakrishna.pai@bme.gatech.edu](balakrishna.pai@bme.gatech.edu)  \n[www. nature.com/scientificreports/](www. nature.com/sci","cbCaip66XTSOpZcy","https://ap.wps.com/l/cbCaip66XTSOpZcy","pdf",3879152,17,"English","# Background\n## Triple negative breast cancer characteristics and treatment limitations\n# Drug repurposing strategy\n## Rationale for studying dapivirine\n# Experimental findings\n## Effects on TNBC cells and apoptosis\n## Proteomics and signaling pathway deregulation","[{\"question\":\"Why was dapivirine selected for study in triple negative breast cancer cells?\",\"answer\":\"Dapivirine is an HIV NNRTI that can be detected in breast milk of lactating women treated for HIV, suggesting it could potentially target cancer cells. The study also focuses on drug repurposing to accelerate availability of effective therapies.\"},{\"question\":\"How does dapivirine affect TNBC cells compared with other NNRTIs?\",\"answer\":\"Dapivirine shows a potent impact on MDA-MB-231 TNBC cells, while NNRTIs such as nevirapine show only marginal effects. It also exhibits inhibition at higher concentrations on other breast cell lines.\"},{\"question\":\"What molecular processes and pathways are implicated by dapivirine treatment?\",\"answer\":\"Molecular studies indicate increased reactive oxygen species, apoptotic cells, and caspase activation. Protein profiling and STRING analysis reveal deregulation of PCNA and effects on signaling circuits involving ECM, angiogenesis, cell adhesion, and immunomodulation, including potential stem-like cell influence via BTF3 and proteasome-related components.\"}]","Multifaceted impact of HIV inhibitor dapivirine on triple negative breast cancer cells reveals potential entities as targets for novel therapy | PDF",1790011563,43]